Tenecteplase
Basilar Artery Occlusion
Xuanwu Hospital, Beijingprotein_peptidePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Basilar Artery Occlusion cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ALTEPLASE The First Affiliated Hospital of University of Science and Technology of China | Phase 3 | BB |
Minocycline Xijing Hospital | Phase 4 | B |
Cerebrolysin University Hospital Sestre Milosrdnice | Early Phase 1 | C |
Unfractionated Heparin Sunnybrook Health Sciences Centre | N/A | D |
Aspirin Sunnybrook Health Sciences Centre | N/A | D |
Same molecule, other indications
Tenecteplase is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →